Karuna Therapeutics, Inc.
KRTXDelisted Mar 18, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001771917
Karuna Therapeutics, Inc. was delisted on Mar 18, 2024; its insiders filed their last Form 4 on Mar 18, 2024; 328 institutions reported holding it in 13F filings for Q4 2023, worth $12.0B in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Karuna Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Of which not filed for Q2 2021 | Q2 2021 | Change |
|---|---|---|---|---|
| Holders | 157 | 1 | 160 | +4 |
| Shares | 25.2M | 2.50K | 25.8M | +604.4K (+2.4%) |
| Value | $3.02B | $301.0K | $2.93B | −$90.0M (−3.0%) |
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (25)
Institutions that held Karuna Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (21)
Institutions that held Karuna Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Marshall Wace, LLP | 45,861 | $5.51M |
| California Public Employees Retirement System | 32,100 | $3.86M |
| Pinz Capital Management, LP | 28,805 | $3.46M |
| LMR Partners LLP | 20,000 | $2.40M |
| Atika Capital Management LLC | 11,000 | $1.32M |
| Aviva PLC | 10,579 | $1.27M |
| Moody Aldrich Partners LLC | 9,929 | $1.19M |
| Marshall Wace North America L.P. | 4,369 | $526.0K |
| Gsa Capital Partners LLP | 3,299 | $397.0K |
| Millennium Management LLC | 3,137 | $377.0K |
| Tudor Investment Corp Et Al | 2,779 | $334.0K |
| Paloma Partners Management Co | 2,361 | $284.0K |
| L & S Advisors Inc | 2,000 | $240.0K |
| Envestnet Asset Management Inc | 1,838 | $221.0K |
| IFP Advisors, Inc | 1,039 | $127.0K |
| Bank of Montreal | 684 | $81.0K |
| Pacer Advisors, Inc. | 650 | $78.0K |
| FORA Capital, LLC | 554 | $67.0K |
| Valeo Financial Advisors, LLC | 107 | $13.0K |
| Eaton Vance Management | 49 | $6.00K |
| Sowell Financial Services LLC | 6 | $1.00K |
Not filed for Q2 2021 yet (1)
Institutions that held Karuna Therapeutics, Inc. at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Amundi Asset Management US, Inc. | 2,500 | $301.0K |